After more than 8 months of the company secretary vacancy, *ST Spring's post-85 female legal representative and proxy Fu Xiaopeng fills the position

robot
Abstract generation in progress

Ruicai Finance Liu Zhiying On April 7, *ST Spring(SH600381) announced that Li He resigned from the position of the company’s director for personal reasons. After his resignation, he will no longer hold any position in the company, and there are no unfulfilled public commitments. Li He does not hold any shares in the company.

The company convened the 18th meeting of the ninth session of the Board of Directors, which deliberated and approved the proposal on “Appointment of the Company’s Board Secretary.” It agreed to appoint Fu Xiaopeng as the company’s Board Secretary. The term shall be from the date the Board approves the appointment until the end of the ninth session of the Board of Directors.

According to the information, Li He was born in May 1980. He holds a master’s degree and is a certified public accountant, and a representative for sponsors. From July 2009 to December 2014, he served as an executive director at the China Minzu Securities Investment Banking Headquarters. From January 2015 to July 2018, he served as the managing general manager at Guotai Junan Innovation Investment Co., Ltd. From July 2018 to November 2020, he served as general manager at Beijing Zhongjing Gelong Investment Consulting Co., Ltd. From May 2019 to May 2020, he served as an independent director of *ST Spring. From December 2020 to February 2025, he served as general manager of the capital markets division at Chang’an International Trust Co., Ltd. Starting from February 2025, he has served as the assistant general manager of *ST Spring.

Fu Xiaopeng, female, was born in December 1986 and holds a bachelor’s degree. She has previously worked in the finance departments of Harbin Borui Power Equipment Co., Ltd. and Qinghai Xinneng Hydropower Development Co., Ltd. In September 2010, she worked at Qinghai Chuntian Medicinal Resources Technology Utilization Co., Ltd. as an accountant. From August 2016 to the present, she has served as the securities affairs representative of Qinghai Chuntian Medicinal Resources Technology Co., Ltd. Fu Xiaopeng does not hold any shares of *ST Spring.

According to the records, the previous Board Secretary of *ST Spring was Chen Ding. This time, the new Board Secretary took office more than 8 months after Chen Ding left.

On July 21, 2025, *ST Spring announced that Chen Ding resigned as the company’s Board Secretary due to a change in his job position. He will continue to serve as a director, deputy general manager, and in positions at its subsidiaries. During the vacancy of the Board Secretary position, Director Li He was designated to perform the duties of the Board Secretary.

On October 20, 2025, *ST Spring announced that if the vacancy of the company’s Board Secretary exceeds three months, the chairman shall perform the duties of the Board Secretary. Therefore, from the date this announcement is disclosed, the company’s chairman Zhang Xuefeng will perform the duties of the Board Secretary.

*ST Spring was established on 1998-08-28. Its legal representative is Zhang Xuefeng. Its registered capital is 5.87 billion yuan. Its main business includes the research, production, and sales of cordyceps products, as well as the sales of alcoholic beverage products. The company’s main products are high-end baijiu, and wild cordyceps raw grass.

*ST Spring expects that in 2025, it will achieve a net profit attributable to shareholders of the listed company of between -4400 million yuan and -5950 million yuan, and a net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses of between -5640 million yuan and -7190 million yuan, indicating that it will incur a loss.

The company expects that in 2025, it will achieve operating revenue of between 3.43 billion yuan and 3.71 billion yuan. Operating revenue after deducting business income unrelated to its main business and income that lacks commercial substance will be between 3.38 billion yuan and 3.67 billion yuan.

*ST Spring stated that the data used in this performance forecast for the current period have not been audited. The company’s stock has been subject to delisting risk warning since April 30, 2025. If the relevant audited financial data for 2025 still meet the financial delisting indicators stipulated in the “Shanghai Stock Exchange Stock Listing Rules” or if there are other circumstances that cannot remove the delisting risk warning, the company’s stock will be terminated from listing.

View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin